NCT05896930

Phase 2Interventional

Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.

View on ClinicalTrials.gov ↗

Timeline

Start date: Nov 9, 2017
Primary completion: Jan 4, 2021
Completion date: Jan 4, 2021
First posted: Jun 9, 2023
Last posted: Jun 9, 2023
Enrollment: 134
Arms / groups: 8 / —
Source: AACT · ctgov ingestion

Drugs studied

rifampin
amoxicillin
cetrorelix
meropenem
ertapenem

Indications studied

Tuberculosis, Pulmonary

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.

NCT05896930

Timeline

Sponsors

Drugs studied

Indications studied